Search Within

Jennifer S Orozco

Formats
  1. Journal Article (3)
  2. Review (3)
  3. Meeting Abstract (2)
Groups
  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. Hematologic Malignancies, Division of (5)
  4. Survivorship Research (3)
  5. Biostatistics Service (2)
  6. Bone Marrow Transplant (2)

More Groups

People
  1. Tim Peterson (4)
  2. Michael Buege (3)
  3. Alexander Lesokhin (2)
  4. Amber King (2)
  5. Andriy Derkach (2)
  6. Carlyn Rose Tan (2)

More People

Years
  1. 2022 (1)
  2. 2021 (2)
  3. 2020 (2)
  4. 2019 (3)
Publications
  1. Annals of Pharmacotherapy (2)
  2. Biology of Blood and Marrow Transplantation (1)
  3. Blood (1)
  4. British Journal of Haematology (1)
  5. Clinical Case Reports (1)
  6. Journal of Oncology Pharmacy Practice (1)

More Publications

Publishers
  1. Sage Publications (2)
  2. American Society of Hematology (1)
  3. Elsevier Inc. (1)
  4. Harborside Press (1)
  5. John Wiley & Sons (1)
  6. Sage Publications Ltd. (1)

More Publishers

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis
    Journal Article

    Piedra, K.; Peterson, T.; Tan, C.; Orozco, J.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Lesokhin, A.; Shah, U.; Lu, S.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma, a real-world experience
    Meeting Abstract

    Hultcrantz, M.; Orozco, J.; Peterson, T. J.; Derkach, A.; Hassoun, H.; Korde, N.; Lu, S. X.; Mailankody, S.; Patel, D.; Shah, U. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City
    Journal Article

    Yerram, P.; Thackray, J.; Modelevsky, L. R.; Land, J. D.; Reiss, S. N.; Spatz, K. H.; Levoir, A. C.; Pak, T. K.; Dao, P. H.; Buege, M. J.; more...
    Journal of Oncology Pharmacy Practice (2021)

    Fulltext@MSK | Save
  • Management of mantle cell lymphoma in the era of novel oral agents
    Review

    Buege, M. J.; Kumar, A.; Dixon, B. N.; Tang, L. A.; Pak, T.; Orozco, J.; Peterson, T. J.; Maples, K. T.
    Annals of Pharmacotherapy (2020)

    Fulltext@MSK | Save
  • Selinexor: A first-in-class nuclear export inhibitor for management of multiply relapsed multiple myeloma
    Review

    Peterson, T. J.; Orozco, J.; Buege, M.
    Annals of Pharmacotherapy (2020)

    Fulltext@MSK | Save
  • Busulfan/melphalan/fludarabine (Bu/Mel/Flu) conditioning versus total body irradiation/thiotepa/cyclophosphamide (HFTBI/Thio/Cy) based conditioning in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) undergoing CD34-selected T-cell depleted allogeneic stem cell transplantation (alloSCT)
    Meeting Abstract

    Orozco, J. S.; Hilden, P.; Maloy, M. A.; Pappacena, J.; Buie, L. W.; Shaffer, B. C.; Papadopoulos, E. B.; Jakubowski, A. A.; Bhatt, V.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Axicabtagene ciloleucel: The first FDA-approved CAR T-cell therapy for relapsed/refractory large B-cell lymphoma
    Review

    King, A. C.; Orozco, J. S.
    Journal of the Advanced Practitioner in Oncology (2019)

    Fulltext@MSK | Save
  • Cobimetinib-induced “dropped head syndrome” and subsequent disease management in an Erdheim-Chester patient
    Journal Article

    King, A. C.; Diamond, E. L.; Orozco, J. S.; Morse, H. R.; Ouyang, L. L.; Schöder, H.; Rampal, R. K.
    Clinical Case Reports (2019)

    Fulltext@MSK | Save